Inhibition of choroidal osteoma progression using bisphosphonate and RANKL-inhibitory treatment

Inhibition of choroidal osteoma progression using bisphosphonate and RANKL-inhibitory treatment

Purpose: To describe the use of anti-osteoclastic medications (i.e., bisphosphonates and receptor activator of nuclear factor kappa beta (RANK) ligand inhibitors) in treating choroidal osteoma. Methods: A 42-year-old male with bilateral posterior choroidal osteomas showed extensive outer retinal atr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mélanie Hébert, Kelly Babic, Edward C. Hsiao, Armin Afshar, Nisha Acharya, John A. Gonzales
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Alphabetic order): bisphosphonates
Choroidal osteoma
Osteoclast activity
Outer retinal layer thickness
Receptor activator of nuclear factor kappa beta ligand inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993624001774
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items